We are live on ! Find out more
VCM

Voleon Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 56.94%
This Fund
S&P 500
This Quarter Est. Return
+31.2%
1 Year Est. Return
+56.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.49B
AUM Growth
+$849M
Cap. Flow
+$57M
Cap. Flow %
1.04%
Top 10 Hldgs %
29.1%
Holding
957
New
177
Increased
251
Reduced
333
Closed
196

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.7M
2
META icon
Meta Platforms (Facebook)
META
+$41.2M
3
MRK icon
Merck
MRK
+$26.1M
4
INTU icon
Intuit
INTU
+$24.7M
5
AZN icon
AstraZeneca
AZN
+$23.6M

Top Sells

Rank Stock Value
1
ALAB icon
Astera Labs
ALAB
+$29.3M
2
QCOM icon
Qualcomm
QCOM
+$28.6M
3
FTNT icon
Fortinet
FTNT
+$26.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$22.1M
5
LLY icon
Eli Lilly
LLY
+$20.8M

Sector Composition

Rank Sector Weight
1 Technology 34.25%
2 Financials 12.04%
3 Healthcare 11.39%
4 Industrials 10.72%
5 Consumer Discretionary 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROP icon
901
Roper Technologies
ROP
$39.2B
– –
-585
Closed -$207K
RSG icon
902
Republic Services
RSG
$69.1B
– –
-7,887
Closed -$1.73M
SAIA icon
903
Saia
SAIA
$9.2B
– –
-629
Closed -$221K
SAP icon
904
SAP
SAP
$247B
– –
-2,986
Closed -$511K
SBR
905
Sabine Royalty Trust
SBR
$1.09B
– –
-4,395
Closed -$331K
SBSW icon
906
Sibanye-Stillwater
SBSW
$8.3B
– –
-225,562
Closed -$2.78M
SEM
907
DELISTED
Select Medical
SEM
– –
-69,812
Closed -$1.14M
SEMR
908
DELISTED
Semrush
SEMR
– –
-44,282
Closed -$529K
SES icon
909
SES AI
SES
$211M
– –
-84,143
Closed -$80.9K
HTO
910
H2O America
HTO
$2.62B
– –
-3,930
Closed -$231K
SMFG icon
911
Sumitomo Mitsui Financial
SMFG
$172B
– –
-24,991
Closed -$494K
SMPL icon
912
Simply Good Foods
SMPL
$878M
– –
-12,810
Closed -$184K
SMR icon
913
NuScale Power
SMR
$3.44B
– –
-169,361
Closed -$1.84M
SMWB icon
914
Similarweb
SMWB
$749M
– –
-88,704
Closed -$232K
SNDX icon
915
Syndax Pharmaceuticals
SNDX
$1.65B
– –
-36,633
Closed -$856K
SPXC icon
916
SPX Corp
SPXC
$9.22B
– –
-3,639
Closed -$728K
SRAD icon
917
Sportradar
SRAD
$3.89B
– –
-50,815
Closed -$851K
SRCE icon
918
1st Source
SRCE
$2.1B
– –
-6,299
Closed -$436K
TEAM icon
919
Atlassian
TEAM
$46.9B
– –
-21,730
Closed -$1.48M
TGB
920
Trekor Metals
TGB
$2.79B
– –
-63,225
Closed -$408K
THC icon
921
Tenet Healthcare
THC
$21.2B
– –
-9,781
Closed -$1.85M
THG icon
922
Hanover Insurance
THG
$8.02B
– –
-2,608
Closed -$452K
TMP icon
923
Tompkins Financial
TMP
$1.42B
– –
-3,276
Closed -$258K
TRI icon
924
Thomson Reuters
TRI
$45.1B
– –
-3,378
Closed -$309K
TROW icon
925
T. Rowe Price
TROW
$22.6B
– –
-4,096
Closed -$369K
35 36
37
38 39

Similar funds

GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Voleon Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Voleon Capital Management held 957 positions worth $5.49B, up 18% from $4.64B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Voleon Capital Management's Q2 2026 filing shows 177 new, 251 increased, 333 reduced and 196 closed positions. Its largest new stake was AstraZeneca: 125,385 shares worth $23.8M. The largest sale was Astera Labs, an estimated $29.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Voleon Capital Management's largest Q2 2026 buy was AstraZeneca: 125,385 shares worth $23.8M.
  • Voleon Capital Management added most to Microsoft in Q2 2026, an estimated $41.7M increase.
  • Voleon Capital Management's biggest Q2 2026 reduction was Astera Labs, cutting an estimated $29.3M.
  • Voleon Capital Management fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $15.5M.
  • Voleon Capital Management's ten largest holdings make up 29% of its $5.49B portfolio in Q2 2026.
  • Voleon Capital Management opened 177 new positions and closed 196 in Q2 2026.
  • Voleon Capital Management's portfolio value rose 18% quarter-over-quarter to $5.49B.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.